News
Indian Pharma Exports Rose By 8% In The Q1 To $6.26 Billion
Indian pharmaceutical exports increased by 8% in the first quarter of the current fiscal year to $6.26 billion, with officials anticipating a 10% increase by year's end.
Pharma exports to the European Union and other CIS countries, which were affected...
Drug Research
GenKOre- Korea Creating Base-Editing Tech For Genetic Issues
Adenine base editors were successfully created by GenKOre, a biotech startup in South Korea, using its unique hypercompact gene-editing method.
The hypercompact ABEs created by GenKOre are distinguished by their small size, ability to be delivered via an adeno-associated virus...
Drug Research
NICE Has Granted Its Endorsement To Beovu From Novartis
Following NICE's recommendation of a novel therapy alternative for diabetic macular oedema (DMO), thousands of patients could receive transformative care. In the final form of the guidance, brolucizumab, also known as Beovu, is suggested as a treatment for adults...
Drug Research
Lilly, AZ, AbbVie, J&J May Be Hit By Medicare Pricing Bill
Could the Senate adopt a "watershed" bill allowing drug price discussions after years of government inaction regarding medication prices in the U.S.? Analysts are busy studying the information at hand to determine how the legislation would impact the leading companies...
IT & Data Management
Cyclerion Provides Information On Schizophrenia Treatment
Positive top-line statistics from Cyclerion Therapeutics' clinical investigation of CY6463 for the treatment of cognitive impairment associated with schizophrenia have been released. It concerns people with stable schizophrenia who are taking a stable dose of a single atypical antipsychotic...
Clinical Trials
Tallac Reveal They Have Served Their First TAC-001 Patient
In a phase 1/2 clinical trial for patients with locally advanced or metastatic solid tumours, Tallac Therapeutics has reported that the first patient has received treatment with TAC-001. TAC-001 is the first clinical candidate from the company's innovative toll-like...
Drug Research
September May Bring Updated COVID-19 Booster Shots To Market
According to the US Department of Health and Human Services, booster shots from Moderna and Pfizer that have been upgraded to target Omicron coronavirus subvariants may be made accessible in the early fall, subject to approval by federal health...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read